CQDM is proud to partner with BIOTECanada to present the next Bio+ech Connec+ event featuring Merck. Bio+ech Connec+, a unique forum for early-stage Canadian biotech companies to connect directly with the business development and investment leaders of multinational pharma/biotech companies.
This virtual forum will include a plenary session led by Lizabeth Leveille Vice President, Business Development & Licensing, Head, Boston & European Innovation Hubs & Discovery Transactions and Marwan Akar President & Managing Director – Merck Canada will provide an overview of the company, its R&D priorities including its pipeline and corresponding investment priorities for the period ahead. Merck representatives will then engage in a Q&A session with the plenary audience. Following the plenary and Q&A, a select group of early-stage companies will be provided an opportunity to connect bilaterally with the Merck representatives.